Post-operative Pain Control After C-section
This study is looking at ways to manage pain after a C-section (cesarean delivery). Researchers want to see if using an ON-Q Pump® that continuously delivers bupivacaine (a local anesthetic, or numbing medicine) helps reduce the amount of opioid pain medicine you need after surgery. You could be eligible if you are a pregnant patient, aged 18 to 50, and are having a C-section at Children's Hospital Colorado's Colorado Fetal Care Center. The study will compare pain control using bupivacaine to a pump delivering saline (salt water). The main goal is to measure how much opioid pain medicine participants use up to four days after surgery. The current status of this study is unclear.
- Study design
- This is an interventional study planning to enroll 100 women. Participants will be randomly assigned to receive either bupivacaine or saline through a pump.
- What's involved
- You would have an ON-Q Pump® connected to a catheter and left in place for up to 4 days after your C-section, or until the infusion is complete.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your opioid use will be measured up to post-operative day 4.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Post-operative Cesarean Trial of Pain Control
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Michael Zaretsky, MD · PRINCIPAL_INVESTIGATOR · Children's Hospital Colorado - Colorado Fetal Care Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Total postoperative opioid usePost-operative day 4
Total postoperative opioid use in morphine equivalents through discharge